SUMMARY Serum lysozyme activities and semiquantitative analysis of tissue lysozyme distribution were studied in patients with primary biliary cirrhosis (PBC), chronic hepatitis (CH), miscellaneous liver diseases, and normal subjects. Serum lysozyme was significantly raised in PBC and CH. Portal venous blood has similar lysozyme activities to peripheral venous blood in a group of various liver diseases. Lysozyme-containing intralobular cells were decreased in all liver diseases studied but portal tract lysozyme was increased only in PBC and CH. Thus the increase in serum lysozyme in PBC and CH appears to originate from the portal inflammatory infiltrate, seen in these diseases.
There have been several studies of serum lysozyme as a possible marker of chronic inflammatory activity. Raised activity has been reported in sarcoidosis, correlating with extent and activity of the disease,' and in tuberculosis. 23 Many investigations of serum lysozyme have been carried out in inflammatory bowel disease4'8 but results are conflicting. The rationale for these studies is that lysozyme is found in granulocytes, monocytes, and macrophages and is more abundant in cells involved in active inflammation than in normal tissue.9 '0 Lysozyme is also found in Kupffer cells. 
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Serum lysozyme activities were significantly raised in PBC (p < 0.001) and CH (p < 0.01) but there was no significant difference between these two groups. The miscellaneous liver disease group was not significantly different from normals but the vanation in the group was very large (Fig. 1) Manifold, Bishop, Cloke, Triger, Underwood intralobular cells in disease groups than normals but no significant difference between groups (Fig. 3) . On examining portal tracts there was significantly more lysozyme in both PBC and CH than in either normals or the miscellaneous disease group (Fig. 4) . There was no difference between PBC and CH and no difference between normals and the miscellaneous group (Tables 1 and 2 ).
Discussion
We have demonstrated that serum lysozyme is raised in PBC and CH and that peripheral and portal blood activities do not differ significantly in the group studied. There was a depletion of hepatic lobular lysozyme-positive cells in liver disease and an increase in lysozyme-positive portal cells in PBC and CH. The very wide variation in serum activity in the miscellaneous group suggests that larger samples of the separate diseases in this group should be studied.
There was too much overlap in serum lysozyme between PBC and CH and between these conditions and normals for the measurement to be of diagnostic value. The spleen and gastrointestinal tract are possible sources of lysozyme contributing to serum activity; Paneth cells of the small intestine contain granules rich in lysozyme'9 and we have noted lysozyme activities in splenic homogenates considerably higher than in serum. However, in the group of various liver diseases studied here the overall lack of significantly higher values in portal blood suggests that the gastrointestinal tract and spleen do not make the major contribution to serum lysozyme activity.
The histological findings suggest two possible mechanisms for the raised serum lysozyme activities in PBC and CH. Firstly, the lack of positive intralobular sinusoidal-lining cells (presumed Kupffer cells) indicates a possible total discharge of lysozyme from many of them into the circulation. This would be analogous to the mechanism suggested for coeliac disease20 of total enzyme discharge from Paneth cell granules into the blood to explain the observed decrease in small intestinal tissue lysozyme and increase in serum lysozyme21 which is seen in this condition.
Secondly, the enzyme could be released primarily by the lysozyme-positive elements of the portal tract infiltrate, which are seen in increased numbers only in PBC and CH in our study. This second hypothesis seems more attractive since:
(a) the portal tracts are the obvious centres of origin of inflammatory activity in these diseases. (b) we observed more lysozyme in tracts which had damaged architecture than in those architecturally normal, although this observation would not be amenable to quantification. (c) macrophages in culture are seen to synthesise and secrete large amounts of lysozyme rather than to discharge it totally.22 (d) raised serum lysozyme activities are seen in viral hepatitis," a condition associated initially with Kiipffer cell proliferation rather than depletion.
Lysozyme has been found in granulocytes and it has been suggested23 that the serum activities in normal individuals largely reflect the rate of physiological granulocyte turnover. It has also been suggested5 that any severe infection will increase lysozyme release because of leucocyte destruction. Our findings of a correlation between serum lysozyme and peripheral granulocyte counts in normal individuals is in accord with a granulocyte origin of serum lysozyme in this group. However the cellular inflammatory infiltrate in the liver in PBC and CH is almost completely composed of mononuclear cells such that granulocyte lysozyme would seem to be of little importance in the excessive production of the enzyme in these diseases. The pathological significance of the correlation between peripheral blood monocyte counts and serum lysozyme in PBC is offset by the fact that the mean monocyte count was lower in PBC than in controls (0.26 x 109/l v 0-46 x 10/1), whereas the mean serum lysozyme was higher in PBC than in controls. This suggests that lysozyme secreted by circulating monocytes is not the cause of the observed difference in serum activities. Also the similarity between mean creatinine concentrations in normals and patients and the lack of correlation with serum lysozyme suggests that the raised lysozyme activities are not due to any impairment of renal excretion in liver disease.
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